<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p152" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_152{left:4px;top:233px;letter-spacing:-0.1px;}
#t2_152{left:4px;top:78px;letter-spacing:-0.3px;}
#t3_152{left:5px;top:629px;}
#t4_152{left:52px;top:40px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#t5_152{left:122px;top:40px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#t6_152{left:52px;top:58px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#t7_152{left:61px;top:75px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#t8_152{left:61px;top:93px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#t9_152{left:61px;top:110px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#ta_152{left:61px;top:127px;letter-spacing:-1px;word-spacing:-0.2px;}
#tb_152{left:61px;top:145px;letter-spacing:-1px;word-spacing:-0.2px;}
#tc_152{left:61px;top:162px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#td_152{left:61px;top:180px;letter-spacing:-1px;word-spacing:-0.1px;}
#te_152{left:52px;top:197px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#tf_152{left:61px;top:215px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#tg_152{left:61px;top:232px;letter-spacing:-1px;}
#th_152{left:67px;top:232px;letter-spacing:-0.9px;word-spacing:0.4px;}
#ti_152{left:67px;top:247px;letter-spacing:-1px;}
#tj_152{left:61px;top:265px;letter-spacing:-1px;word-spacing:-0.1px;}
#tk_152{left:61px;top:282px;letter-spacing:-1px;word-spacing:-0.2px;}
#tl_152{left:43px;top:317px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#tm_152{left:52px;top:335px;letter-spacing:-1px;}
#tn_152{left:59px;top:335px;letter-spacing:-1px;word-spacing:-0.1px;}
#to_152{left:61px;top:352px;letter-spacing:-1px;word-spacing:0.2px;}
#tp_152{left:61px;top:367px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#tq_152{left:61px;top:385px;letter-spacing:-1px;word-spacing:1.1px;}
#tr_152{left:61px;top:400px;letter-spacing:-1px;word-spacing:-1.6px;}
#ts_152{left:61px;top:415px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#tt_152{left:52px;top:433px;letter-spacing:-0.9px;word-spacing:1.1px;}
#tu_152{left:114px;top:433px;letter-spacing:-1px;word-spacing:1.4px;}
#tv_152{left:279px;top:433px;letter-spacing:-0.9px;word-spacing:1.4px;}
#tw_152{left:52px;top:448px;letter-spacing:-1px;word-spacing:-0.1px;}
#tx_152{left:43px;top:483px;letter-spacing:-1px;word-spacing:-0.2px;}
#ty_152{left:52px;top:500px;letter-spacing:-1px;}
#tz_152{left:60px;top:500px;letter-spacing:-1px;word-spacing:0.5px;}
#t10_152{left:165px;top:500px;letter-spacing:-1px;word-spacing:0.6px;}
#t11_152{left:60px;top:516px;letter-spacing:-1px;}
#t12_152{left:52px;top:533px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#t13_152{left:122px;top:533px;letter-spacing:-1px;word-spacing:-0.1px;}
#t14_152{left:52px;top:551px;letter-spacing:-1px;}
#t15_152{left:60px;top:551px;letter-spacing:-1px;}
#t16_152{left:124px;top:551px;letter-spacing:-1px;word-spacing:15.9px;}
#t17_152{left:60px;top:566px;letter-spacing:-1px;word-spacing:-0.1px;}
#t18_152{left:52px;top:583px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#t19_152{left:111px;top:583px;letter-spacing:-1px;word-spacing:-0.1px;}

.s1_152{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_152{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_152{
	FONT-SIZE: 39.7px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_152{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.s5_152{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.t.m0_152{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts152" type="text/css" >

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg152Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg152" style="-webkit-user-select: none;"><object width="433" height="649" data="152/152.svg" type="image/svg+xml" id="pdf152" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_152" class="t m0_152 s1_152">O Guia do Jovem Internista </div>
<div id="t2_152" class="t m0_152 s2_152">2016</div>
<div id="t3_152" class="t s3_152">150</div>
<div id="t4_152" class="t s4_152">• Diagnóstico: </div>
<div id="t5_152" class="t s5_152">Consoante da manifestação clínica </div>
<div id="t6_152" class="t s4_152">• Tratamento: </div>
<div id="t7_152" class="t s5_152">- Primeiros 2meses: INH + (RIF ou RFB) + EMB + PZA </div>
<div id="t8_152" class="t s5_152">- Após 2meses: INH + (RIF ou RFB) </div>
<div id="t9_152" class="t s5_152">- INH - 5mg/kg/dia (300mg)</div>
<div id="ta_152" class="t s5_152">- RIF - 10mg/kg/dia (600mg); RFB - 5mg/kg/dia (300mg)</div>
<div id="tb_152" class="t s5_152">- EMB - 40-55kg 800mg, 56-75kg 1200mg, &gt;76kg 1600mg</div>
<div id="tc_152" class="t s5_152">- PZA - 40-55kg 1000mg, 56-75kg 1500mg, &gt;76kg 2000mg </div>
<div id="td_152" class="t s5_152">- Corticoterapia -- se envolvimento do SNS ou pericárdio</div>
<div id="te_152" class="t s4_152">• Duração do tratamento: </div>
<div id="tf_152" class="t s5_152">- TB pulmonar, sem resistência - 6meses</div>
<div id="tg_152" class="t s5_152">- </div>
<div id="th_152" class="t s5_152">TB pulmonar + culturas positivas após 2 meses de tratamento - 9 </div>
<div id="ti_152" class="t s5_152">meses</div>
<div id="tj_152" class="t s5_152">- TB extrapulmonar com envolvimento de SNC - 9-12 meses</div>
<div id="tk_152" class="t s5_152">- TB óssea ou extrapulmonar com outras localizações- 6-9meses</div>
<div id="tl_152" class="t s4_152">• Profilaxia</div>
<div id="tm_152" class="t s4_152">- </div>
<div id="tn_152" class="t s4_152">Primária ou tratamento de tuberculose latente</div>
<div id="to_152" class="t s5_152">Teste cutâneo (+) (&gt;5mm), sem evidência de TB ativa, sem história </div>
<div id="tp_152" class="t s5_152">prévia de TB </div>
<div id="tq_152" class="t s5_152">Teste cutâneo (-) mas contacto próximo com doente com TB, sem </div>
<div id="tr_152" class="t s5_152">evidência de TB activa ou história de TB não adequadamente tratada </div>
<div id="ts_152" class="t s5_152">sem evidência de TB activa </div>
<div id="tt_152" class="t s4_152">- Esquemas: </div>
<div id="tu_152" class="t s5_152">INH 300mg PO + Piridoxina 40mg </div>
<div id="tv_152" class="t s5_152">ou INH 900 mg PO </div>
<div id="tw_152" class="t s5_152">2xsemana + Piridoxina 40mg 6/6h. 9 meses de tratamento.</div>
<div id="tx_152" class="t s4_152">• Micobacterium Avium Complex</div>
<div id="ty_152" class="t s4_152">• </div>
<div id="tz_152" class="t s4_152">Manifestação clínica:</div>
<div id="t10_152" class="t s5_152">progressão indolente, febre, perda ponderal, </div>
<div id="t11_152" class="t s5_152">organomegalias, linfadenopatias, anemia</div>
<div id="t12_152" class="t s4_152">• Diagnóstico:</div>
<div id="t13_152" class="t s5_152">Isolamento de MAC</div>
<div id="t14_152" class="t s4_152">• </div>
<div id="t15_152" class="t s4_152">Tratamento:</div>
<div id="t16_152" class="t s5_152">claritromicina 500mg 2xdia ou Azitromicina 500-</div>
<div id="t17_152" class="t s5_152">600mg + Etambutol 15mg/kg 1xdia</div>
<div id="t18_152" class="t s4_152">• Profilaxia: </div>
<div id="t19_152" class="t s5_152">CD4 &lt;50cels/μL e após exclusão de doença activa.</div>

<!-- End text definitions -->


</div>
</body>
</html>
